FINCH THERAPEUTICS GROUP INC's ticker is FNCH and the CUSIP is 31773D101. A total of 46 filers reported holding FINCH THERAPEUTICS GROUP INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $22,794 | -18.1% | 58,000 | 0.0% | 0.00% | – |
| Q4 2022 | $27,840 | -71.3% | 58,000 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $97,000 | -41.2% | 58,000 | 0.0% | 0.00% | -66.7% |
| Q2 2022 | $165,000 | -43.5% | 58,000 | 0.0% | 0.00% | -25.0% |
| Q1 2022 | $292,000 | -49.5% | 58,000 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $578,000 | -23.3% | 58,000 | 0.0% | 0.01% | +100.0% |
| Q3 2021 | $754,000 | -10.7% | 58,000 | -3.3% | 0.00% | -40.0% |
| Q2 2021 | $844,000 | -14.4% | 60,000 | -3.2% | 0.01% | 0.0% |
| Q1 2021 | $986,000 | – | 62,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avenir Management Company, LLC | 55,445 | $472,946 | 1.27% |